Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Accelerated Bio AB
AB
Active
Org 5594296443
Hårdvallsgatan 14
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 0
EBITDA margin
—
-13% vs 2023
Equity ratio
60.6%
Financial strength
Net profit 2024
SEK -26K
-13% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
SEK -26K
-13%
Net profit
SEK -26K
-13%
Total assets
SEK 127K
+3%
Equity
SEK 77K
-25%
Employees
0
—
Company information
Legal name
Accelerated Bio AB
Org number
5594296443
Legal form
Aktiebolag
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
11 april 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall äga och utveckla biotekniska innovationer, patent och immateriella rättigheter, samt bedriva därmed förenlig verksamhet.
Contact
Address
Hårdvallsgatan 14
Email
sophia@hoberbiotech.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
0
0
Staff expenses
—
—
EBITDA
−23
−26
Depreciation & amort.
−0
−0
EBIT
−23
−26
Net financials
—
—
Profit before tax
−23
−26
Tax
−0
−0
Net profit
−23
−26
Balance sheet
SEK thousands
Item
2023
2024
Total assets
123
127
Equity
103
77
Long-term debt
0
0
Short-term debt
20
51
Total debt
20
51
Financial ratios
5-year trend
EBITDA margin
-2600000.0%
This company
15.8%
Market median
-16455796% vs market
2023
2024
Equity ratio
60.6%
This company
38.2%
Market median
+59% vs market
2023
2024
Return on equity
-33.8%
This company
18.4%
Market median
-284% vs market
2023
2024
Net profit margin
-2600000.0%
This company
8.1%
Market median
-32098865% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HH
Hök Hans Olov Erik Forsberg
Audit
Audit
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
SE
Sophia Elisabeth Hober
Chairman
2023
JA
Johan Arthur Gustavsson
Board of Directors
2023
DM
Dag Magnus Hober
Deputy Board Member
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Hober Biotech AB
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Hober Biotech AB
Accelerated Bio AB
(this company)
Board network connections
Board members of Accelerated Bio AB also hold positions in
0
other companies.
Person
Role here
Other companies
Hök Hans Olov Erik Forsberg
Audit
0 companies
Sophia Elisabeth Hober
Chairman
0 companies
Johan Arthur Gustavsson
Board of Directors
0 companies
Dag Magnus Hober
Deputy Board Member
0 companies